BAKER BROS. ADVISORS LP – Denali Therapeutics Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$18.06M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
+4.28%
quarter
Denali Therapeutics Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 741K | $30.69 | 588.73K | |
| Q2 2022 | share | Increase | +563.46% | 500K shares | 14.47M | $29.43 | 588.73K |
| Q1 2022 | share | 0.00% | 0 shares | -1.10M | $32.17 | 88.73K | |
| Q4 2021 | share | 0.00% | 0 shares | -519K | $45.05 | 88.73K | |
| Q3 2021 | share | 0.00% | 0 shares | -2.48M | $50.45 | 88.73K | |
| Q2 2021 | share | 0.00% | 0 shares | 1.89M | $78.44 | 88.73K | |
| Q1 2021 | share | 0.00% | 0 shares | -2.36M | $57.1 | 88.73K | |
| Q4 2020 | share | Decrease | -10.73% | -10.66K shares | 3.87M | $83.76 | 88.73K |
| Q3 2020 | share | Decrease | -5.24% | -5.5K shares | 1.02M | $35.83 | 99.4K |
| Q2 2020 | share | 0.00% | 0 shares | 699K | $24.18 | 104.9K | |
| Q1 2020 | share | Increase | 0.00% | 104.9K shares | 1.83M | $17.51 | 104.9K |